Arthritis Market Research Reports & Industry Analysis
Rheumatoid arthritis (RA) is a systemic inflammatory disease. In the United States, approximately a single percent of the population is affected. Women are two to three times more likely to develop rheumatoid arthritis than men, with peak incidence between the fourth and sixth decades. Gender difference disappears in older age. Rheumatoid arthritis affects all races, and its prevalence is not affected by climate. Eighty percent of rheumatoid arthritis patients test rheumatoid factor (RF) positive.
Arthritis Industry Research & Market Reports
-
Acute Gout Flare - Pipeline Insight, 2024
... Flare market. A detailed picture of the Acute Gout Flare pipeline landscape is provided, which includes the disease overview and Acute Gout Flare treatment guidelines. The assessment part of the report embraces in-depth Acute Gout ... Read More
-
Psoriatic Arthritis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Gouty Arthritis (Gout) - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Erosive Hand Osteoarthritis - Pipeline Insight, 2024
... Osteoarthritis market. A detailed picture of the Erosive Hand Osteoarthritis pipeline landscape is provided, which includes the disease overview and Erosive Hand Osteoarthritis treatment guidelines. The assessment part of the report embraces in-depth Erosive Hand ... Read More
-
Knee osteoarthritis – Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Juvenile Idiopathic arthritis (JIA) - Pipeline Insight, 2024
... the Juvenile Idiopathic arthritis (JIA) market. A detailed picture of the Juvenile Idiopathic arthritis (JIA) pipeline landscape is provided, which includes the disease overview and Juvenile Idiopathic arthritis (JIA) treatment guidelines. The assessment part of ... Read More
-
Polyarticular Juvenile Idiopathic Arthritis - Pipeline Insight, 2024
... the Polyarticular Juvenile Idiopathic Arthritis market. A detailed picture of the Polyarticular Juvenile Idiopathic Arthritis pipeline landscape is provided, which includes the disease overview and Polyarticular Juvenile Idiopathic Arthritis treatment guidelines. The assessment part of ... Read More
-
Axial spondyloarthritis (axSpA) - Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Rheumatoid Arthritis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Autoimmune Drugs Market Size, Trends, Analysis, and Outlook By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital, Pharmacy, Drug Store/Retail Pharmacy, Online), by Region, Country, Segment, and Companies, 2024-2030
... The global Autoimmune Drugs market size is poised to register 6.93% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Drugs ... Read More
-
Porcine Vaccine Market Size, Trends, Analysis, and Outlook By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others), By Disease (Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCVAD), Others), by Region, Country, Segment, and Companies, 2024-2030
... Circovirus Associated Disease (PCVAD), Others), by Region, Country, Segment, and Companies, 2024-2030 The global Porcine Vaccine market size is poised to register 6.97% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Anti-inflammatory Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Nonsteroidal Anti-inflammatory Diseases (NSAIDs), Corticosteroids, Biologics), By Indication (Arthritis, Respiratory Disease, Multiple Sclerosis, Psoriasis, Anti-inflammatory Bowel Disease (IBD), Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Anti-inflammatory Therapeutics market size is poised to register 6.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Canine Arthritis Treatment Market Size, Trends, Analysis, and Outlook By Type (Surgery, Drugs, Others), By Route of Administration (Oral, Parenteral, Others), By Treatment (Non-steroidal anti-inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells, Autologous Stem Cells), By End-User (Hospitals, Speciality Clinics, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Stem Cells), By End-User (Hospitals, Speciality Clinics, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Canine Arthritis Treatment market size is poised to register 6.84% ... Read More
-
Orthobiologics Market Assessment, By Product [Demineralized Bone Matrix, Viscosupplements, Synthetic Bone Substitutes, Allografts, Bone Growth Factors, Others], By Application [Reconstructive and Fracture Surgery, Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft Tissue Repair, Maxillofacial and Dental, Others], By End-user [Hospitals, Ambulatory and Trauma Care Centers, Orthopedic Clinics, Dental Clinics and Facilities, Others], By Region, Opportunities and Forecast, 2017-2031F
... Others], By End-user [Hospitals, Ambulatory and Trauma Care Centers, Orthopedic Clinics, Dental Clinics and Facilities, Others], By Region, Opportunities and Forecast, 2017-2031F Global orthobiologics market is projected to witness a CAGR of 6.08% during the ... Read More
-
Tumor Necrosis Factor Inhibitor Drugs Market Size, Trends, Analysis, and Outlook By Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Others), By Sales Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Arthritis, Hidradenitis Suppurativa, Others), By Sales Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Tumor Necrosis Factor Inhibitor Drugs market size is poised to register 1.73% growth ... Read More
-
Medical Marijuana Market Size, Trends, Analysis, and Outlook By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Medical Marijuana market size is poised to register 21.66% growth from 2024 to 2030, presenting significant growth ... Read More
-
Rheumatoid Arthritis Therapeutics Market Size, Trends, Analysis, and Outlook By Pharmaceuticals Molecule (NSAIDs, Analgesics, DMARDs, Glucocorticoids), By Biopharmaceuticals Molecule (Biologics, Biosimilars), By Sales Channel (Prescription, Over-the-Counter), by Region, Country, Segment, and Companies, 2024-2030
... Rheumatoid Arthritis Therapeutics market size is poised to register 4.95% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Rheumatoid Arthritis Therapeutics market ... Read More
-
Geriatric Medicine Market Size, Trends, Analysis, and Outlook By Therapeutics (Analgesic, Antihypertensive, Statins, Antidiabetic, PPI, Anticoagulant, Antipsychotic, Others), By Condition (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory , Others), by Region, Country, Segment, and Companies, 2024-2030
... The global Geriatric Medicine market size is poised to register 7.74% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Geriatric Medicine market ... Read More
-
The 2025-2030 World Outlook for Bioelectric Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Chiropractic Relief Care
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Psoriatic Arthritis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More